Vanguard Group’s TearLab Corporation TEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-51,802
| Closed | -$66K | – | 4152 |
|
|
2017
Q3 | $66K | Sell |
51,802
-2,730
| -5% | -$4.83K | ﹤0.01% | 4015 |
|
|
2017
Q2 | $91K | Sell |
54,532
-21,458
| -28% | -$43.6K | ﹤0.01% | 3993 |
|
|
2017
Q1 | $216K | Buy |
75,990
+2,239
| +3% | +$11.1K | ﹤0.01% | 3893 |
|
|
2016
Q4 | $376K | Sell |
73,751
-8,700
| -11% | -$49.4K | ﹤0.01% | 3786 |
|
|
2016
Q3 | $536K | Sell |
82,451
-147
| -0.2% | -$1.09K | ﹤0.01% | 3746 |
|
|
2016
Q2 | $528K | Buy |
82,598
+310
| +0.4% | +$2.27K | ﹤0.01% | 3777 |
|
|
2016
Q1 | $518K | Buy |
82,288
+100
| +0.1% | +$994 | ﹤0.01% | 3783 |
|
|
2015
Q4 | $1.14M | Buy |
82,188
+690
| +0.8% | +$11.8K | ﹤0.01% | 3578 |
|
|
2015
Q3 | $1.64M | Buy |
81,498
+518
| +0.6% | +$12.1K | ﹤0.01% | 3461 |
|
|
2015
Q2 | $1.64M | Buy |
80,980
+2,561
| +3% | +$60.1K | ﹤0.01% | 3495 |
|
|
2015
Q1 | $1.56M | Hold |
78,419
| – | – | ﹤0.01% | 3494 |
|
|
2014
Q4 | $2.08M | Buy |
78,419
+603
| +0.8% | +$16.6K | ﹤0.01% | 3276 |
|
|
2014
Q3 | $2.65M | Sell |
77,816
-250
| -0.3% | -$10.6K | ﹤0.01% | 3147 |
|
|
2014
Q2 | $3.8M | Sell |
78,066
-7,363
| -9% | -$359K | ﹤0.01% | 2983 |
|
|
2014
Q1 | $5.78M | Buy |
85,429
+3,639
| +4% | +$279K | ﹤0.01% | 2752 |
|
|
2013
Q4 | $7.64M | Buy |
81,790
+8,512
| +12% | +$848K | ﹤0.01% | 2574 |
|
|
2013
Q3 | $8.1M | Buy |
73,278
+20,055
| +38% | +$2.5M | ﹤0.01% | 2495 |
|
|
2013
Q2 | $5.65M | Buy |
+53,223
| New | +$4.87M | ﹤0.01% | 2596 |
|
Other funds holding TEAR
Vanguard Group's TEAR Position: Q4 2017 in Review
Vanguard Group sold out of TearLab Corporation (TEAR) in Q4 2017, closing a stake of 51,802 shares — an estimated $66K sold.
Vanguard Group first reported a position in TEAR in Q2 2013 and held it in 18 quarters. The position peaked at $8.1M in Q3 2013. 3 funds tracked by Wall St. Rank hold TEAR as of Q4 2017.
- Vanguard Group reported no remaining TearLab Corporation position as of Q4 2017 after selling out during the quarter.
- Vanguard Group sold 51,802 TearLab Corporation shares in Q4 2017, an estimated $66K.
- Vanguard Group first reported a position in TearLab Corporation in Q2 2013 and held it in 18 quarters.
- Vanguard Group's TearLab Corporation position peaked at $8.1M in Q3 2013.
- 3 funds tracked by Wall St. Rank held TearLab Corporation as of Q4 2017.
Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.